HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M Labopin Selected Research
M Labopin Research Topics
Disease
19
Leukemia
01/2020 - 08/2001
9
Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 12/2000
9
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 06/2000
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 12/2002
5
Neoplasms (Cancer)
01/2020 - 10/2004
4
Pathologic Complete Response
12/2012 - 06/2000
3
Autoimmune Diseases (Autoimmune Disease)
01/2016 - 06/2012
3
Residual Neoplasm
12/2015 - 10/2004
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2017 - 10/2004
2
Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2017 - 02/2017
2
Systemic Scleroderma (Systemic Sclerosis)
01/2016 - 01/2016
2
Infections
12/2015 - 08/2007
2
Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 08/2007
2
Acute Promyelocytic Leukemia
04/2007 - 12/2000
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1
Mucositis
02/2017
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2016
1
Thrombocytopenia (Thrombopenia)
12/2015
1
Hemorrhagic Cystitis
12/2015
1
Vitamin D Deficiency
09/2015
1
Communicable Diseases (Infectious Diseases)
07/2015
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2013
1
Chromosome Aberrations (Chromosome Abnormalities)
11/2009
1
Cataract (Cataracts)
08/2007
1
Hypothyroidism
08/2007
Drug/Important Bio-Agent (IBA)
3
HLA Antigens (Human Leukocyte Antigens)
IBA
09/2015 - 01/2007
2
Busulfan (Busulfex)
FDA Link
09/2017 - 12/2015
2
Antigens
IBA
02/2016 - 07/2015
2
Dihydrotachysterol (AT 10)
IBA
12/2015 - 08/2007
2
thymoglobulin
FDA Link
01/2015 - 05/2005
2
Cytokines
IBA
07/2014 - 10/2004
2
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
11/2010 - 05/2005
1
Immunosuppressive Agents (Immunosuppressants)
IBA
11/2021
1
HLA-A Antigens (HLA-A)
IBA
01/2021
1
HLA-DQB1 antigen (HLA DQB1)
IBA
01/2021
1
fludarabine
IBA
09/2017
1
Gemtuzumab (Mylotarg)
FDA Link
04/2017
1
Thiotepa (Triethylenethiophosphoramide)
FDA Link
Generic
02/2017
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
01/2017
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
12/2015
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
12/2015
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2015
1
romiplostim
FDA Link
12/2015
1
Vitamin D
FDA Link
Generic
09/2015
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
07/2014
1
Alemtuzumab (Campath)
FDA Link
03/2014
1
N 30
IBA
11/2009
1
KIR Receptors
IBA
03/2009
1
Ligands
IBA
03/2009
Therapy/Procedure
25
Transplantation
01/2020 - 06/2000
16
Stem Cell Transplantation
01/2018 - 10/2004
9
Hematopoietic Stem Cell Transplantation
03/2016 - 05/2005
6
Cell Transplantation
11/2021 - 06/2012
4
Therapeutics
11/2021 - 03/2014
2
Homologous Transplantation
12/2015 - 11/2009
2
Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2001 - 12/2000
1
Drug Therapy (Chemotherapy)
03/2016
1
MDC protocol
04/2014
1
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2007
1
Autologous Transplantation
10/2004